Share >  
Share
Share on Tumblr

Dishman Pharmaceuticals

News »

   latest by relevance
Buy Dishman Pharma; target of Rs 92: Angel Broking
May 21, 2012 at 12:53 | Source: Moneycontrol.com
Angel Broking is bullish on Dishman Pharma and has recommended buy rating on the stock with a target of Rs 92 in its May 15, 2012 research report.
Dishman Pharma Q4 net profit up 36% at Rs 31.3 cr
May 15, 2012 at 17:08 | Source: Moneycontrol.com
Dishman Pharma has reported a growth of 36% year-on-year in its consolidated net profit of Rs 31.3 crore for the fourth quarter of FY12.
Dishman Pharma expects 25% growth in FY13
May 15, 2012 at 16:33 | Source: CNBC-TV18
Dishman Pharmaceuticals posted a 13.24% topline growth in the fourth quarter of FY12 and reported a consolidated net profit of Rs 312.94 million for the quarter ended 31 March, 2012, up 37.30% from Rs 227.92 million in the corresponding quarter last year.
See strong performance by pharma in Mar quarter: KR Choksey
Apr 05, 2012 at 14:45 | Source: Moneycontrol.com
According to the report on earnings preview for the quarter ended March 2012, KR Choksey expects the pharma sector will show strong performance in the domestic pharmaceuticals market mainly due to recovery in Indian pharma market.
Reduce Dishman Pharma; target of Rs 61: KRChoksey
Feb 14, 2012 at 12:31 | Source: Moneycontrol.com
KRChoksey is bearish on Dishman Pharma and has recommended reduce rating on the stock with a target of Rs 61 in its February 13, 2012 research report.
Accumulate Dishman Pharma; target of Rs 64: Dolat Capital
Feb 13, 2012 at 16:01 | Source: Moneycontrol.com
Dolat Capital is bullish on Dishman Pharma and has recommended accumulate rating on the stock with a target of Rs 64 in its February 10, 2012 research report.

Videos »
Dishman Pharma expects 25% growth in FY13
SP Tulsian negative on tyre stocks
Better R&D income led to jump in profits: Dishman Pharma
Creapharm buy funded via internal accruals: Dishman Pharma
FY12 profit to be better than FY11: Dishman Pharma
more »

Photos »

  /  
News across the web »
'BUY' or 'SELL' ideas from experts for Monday, May 28
NEW DELHI: Indian markets are expected to remain rangebound with a positive bias on Monday tracking higher Asian markets. Trading is expected to be subdued on Monday amid a lack of key economic data ...
May 28, 2012 at 09:26 | Source: Economic Times
Dishman Pharma Q4 net up 37% at Rs 31.29 cr
Dishman Pharmaceuticals and Chemicals today reported 37.35 per cent rise in consolidated net profit at Rs 31.29 crore for the quarter ended March 31, 2012. The company had posted net profit of Rs 22....
May 16, 2012 at 05:02 | Source: The Hindu BusinessLine
Dishman to focus on non-European Union territories for CRAMS
Ahmedabad-based Dishman Pharmaceuticals Chemicals Ltd (DPCL) is taking up strategic business overhaul of its European operations. The company is increasing its focus on contract research and manufactu...
May 04, 2012 at 01:06 | Source: Business Standard
Granules India appoints new CFO
Granules India Limited has appointed VVS Murthy as its new chief financial officer (CFO). Murthy previously served as the group CFO at Ahmedabad-based Dishman Pharmaceutical and Chemicals Limited and ...
Apr 30, 2012 at 00:21 | Source: Business Standard
New Granules India CFO
Hyderabad, April 26: Mr V.V.S. Murthy has been appointed Chief Financial Officer (CFO) of Granules India Ltd, a Hyderabad-based, pharmaceutical manufacturing company. Mr Pranesh Raj Mathur, who had t...
Apr 26, 2012 at 14:06 | Source: The Hindu BusinessLine
more »
Interact & exchange stock tips & market info »

Market Statistician

Platinum Member

4341 Followers

Dishman Pharma  

At 14:14 hrs, Dishman Pharmaceuticals & Chemicals was tr...

2.15 PM May 25th

Market Statistician

Platinum Member

4341 Followers

Dishman Pharma  

At 12:14 hrs, Dishman Pharmaceuticals & Chemicals was tr...

12.15 PM May 25th

Market Statistician

Platinum Member

4341 Followers

Dishman Pharma  

At 11:13 hrs, Dishman Pharmaceuticals & Chemicals was tr...

11.15 AM May 25th

Related News »
Buy Dishman Pharma; target of Rs 92: Angel Broking
“For 4QFY2012, Dishman Pharmaceuticals (Dishman) reported lower-thanexpected sales, while its net profit came in above our expectations. Sales and net profit came in at Rs350cr and Rs31cr vs. our expectation of net sales and profit of Rs383cr ...
May 21, 2012 at 07:19 | Source: MoneyControl.com
Dishman Pharmaceuticals & Chemicals - Confidence yet to flow, but operating leverage can deliver - Avendus
DISH's PAT performance during the Mar12 quarter, stood its best since the Dec09 quarter, with flattish revenues on a reasonably large base and expansion in operating margins. The MM business fell 14% during the quarter, nevertheless clocking in ...
May 19, 2012 at 18:12 | Source: equitybulls.com
Dishman Pharmaceuticals 4QFY2012 performance highlights and results update
For 4QFY2012, Dishman Pharmaceuticals (Dishman) reported lower-thanexpected sales, while its net profit came in above our expectations. Sales and net profit came in at Rs.350cr and Rs.31cr vs. our expectation of net sales and profit of Rs.383cr and Rs.
May 16, 2012 at 12:04 | Source: Stock Markets Review
Global Pharmaceutical Contract Manufacturing Industry
The report profiles 82 companies including many key and niche players such as Althea Technologies, Catalent Pharma Solutions, Dishman Pharmaceuticals and Chemicals Ltd, HAUPT Pharma AG, Jubilant Life Sciences Limited, Kemwell Pvt. Ltd ...
May 16, 2012 at 10:59 | Source: Yahoo Finance
Recession lashes global pharmaceutical contract manufacturing industry
The report profiles 82 companies including many key and niche players such as Althea Technologies, Catalent Pharma Solutions, Dishman Pharmaceuticals and Chemicals Ltd, HAUPT Pharma AG, Jubilant Life Sciences Limited, Kemwell Pvt. Ltd, NextPharma ...
May 15, 2012 at 21:30 | Source: Transworld News

Follow moneycontrol.com

Facebook Twitter Google Plus RSS Wap SMS SMS Alert iPad iPhone Blackberry OVI Android Window